AFFYMAX INC | 1,058 Euro | -0,061 -5,45 % | |
| WKN: A0LCV5 ISIN: US00826A1097 Ticker-Symbol: A5Y | Frankfurt | 23.05.13 | 15:32 Uhr |
Branche BiotechnologieAktienmarkt Sonstige |
|
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 14.05. | Affymax CEO steps down as restructuring firm steps in | 21 | bizjournals | |
| 13.05. | Hot Stock: Affymax, Shares Gain 11.8% | 22 | SmarTrend | |
| 10.05. | Affymax Inc is Featured as the Daily Momentum Gainer to Watch on Smallcappower.com | 72 | Newsfile | |
| Toronto, Ontario--(Newsfile Corp. - May 10, 2013) - Leading smallcap investor portal Smallcappower is pleased to highlight Affymax Inc (NASDAQ: AFFY) as their Daily Momentum Gainer to watch. You can... Mehr lesen zu: Affymax Inc is Featured as the Daily Momentum Gainer to Watch on Smallcappower.com | ||||
| 07.05. | Affymax Could Be The Best Reversal Play For 2013 | 90 | Seeking Alpha | |
| 07.05. | Affymax Up 12.1%, Penny Stock Attracts Attention | 50 | SmarTrend | |
| 30.04. | Affymax is Among the Companies in the Biotechnology Industry With the Lowest Sales Growth | 34 | SmarTrend | |
| 29.04. | Possible Bullish Inside Day Candle Pattern Detected for Affymax | 16 | SmarTrend | |
| 25.04. | Affymax is Among the Companies in the Biotechnology Industry With the Lowest Price to Forward Sales | 15 | SmarTrend | |
| 23.04. | Affymax (AFFY) Enters Consulting Agreement with Brenner Group | 19 | StreetInsider.com | |
| 23.04. | AFFYMAX INC - 8-K, Departure of Directors or Certain Officers; Election of Directors; Appointment ... | 3 | SEC Filings | |
| 23.04. | UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Affymax, Inc. of Class Action Lawsuit and the Deadline of April 29, 2013 to Seek a Lead Plaintiff Position | 54 | PR Newswire | |
| NEW YORK, April 23, 2013 /PRNewswire/ -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf... Mehr lesen zu: UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Affymax, Inc. of Class Action Lawsuit and the Deadline of April 29, 2013 to Seek a Lead Plaintiff Position | ||||
| 18.04. | Recent 52-Week Low Surpassed in Shares of Affymax | 16 | SmarTrend | |
| 05.04. | SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors With Losses on Their Investment in Affymax, Inc. of Class Action Lawsuit and the Deadline of April 29, 2013 to Seek a Lead Plaintiff Position | 94 | Marketwired | |
| NEW YORK, NY -- (Marketwired) -- 04/05/13 -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on... Mehr lesen zu: SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors With Losses on Their Investment in Affymax, Inc. of Class Action Lawsuit and the Deadline of April 29, 2013 to Seek a Lead Plaintiff Position | ||||
| 04.04. | Affymax (AFFY) Pays Off Oxford Finance Obligation | 16 | StreetInsider.com | |
| 03.04. | Harwood Feffer LLP Announces Investigation of Affymax, Inc. | 90 | PR Newswire | |
| NEW YORK, April 3, 2013 /PRNewswire/ --Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Affymax, Inc. ("Affymax" or the "Company") (NASDAQ: AFFY)... Mehr lesen zu: Harwood Feffer LLP Announces Investigation of Affymax, Inc. | ||||
| 02.04. | Upcoming Lawsuits Will Likely Leave Affymax Shareholders With Nothing | 16 | Seeking Alpha | |
| 02.04. | Affymax Tanks on Woeful Earnings, May Go Out of Business | 18 | Benzinga.com | |
| 01.04. | Morning Research on Amgen, Affymax, Vertex Pharma, Questcor Pharma, and Repros Therapeutics | 124 | PR Newswire | |
| LONDON, April 1, 2013 /PRNewswire/ --
The healthcare sector is undergoing a major transformation after the Supreme Court last year upheld President Obama's Affordable Care Act (ACA). While supporters... Mehr lesen zu: Morning Research on Amgen, Affymax, Vertex Pharma, Questcor Pharma, and Repros Therapeutics | ||||
| 28.03. | Is It The End Of The Road For Affymax? | 31 | Seeking Alpha | |
| 27.03. | Lowest Price to Forward Sales in the Biotechnology Industry Detected in Shares of Affymax | 19 | SmarTrend | |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| WILEX | 1,43 | -3,57 % | DGAP-HV: Wilex AG: Bekanntmachung der Einberufung -3- |
| EPIGENOMICS | 1,661 | -6,16 % | Epigenomics AG: Ergebnisse der Vergleichsstudie zwischen Epigenomics Epi proColon(R) und FIT werden auf der Digestive Disease Week vorgestellt |
| AGENNIX | 0,096 | -16,52 % | Agennix AG gibt Liquidation bekannt |
| KERYX BIOPHARMACEUTICALS | 6,096 | -1,98 % | Why Keryx is Lagging But Acadia is Zooming (Hint: It's About NCE) |
| XOMA | 3,163 | +3,54 % | Ladenburg hebt das Kursziel für XOMA von $5 auf $6. |
